Inventor · disambiguated record
Charles Price Taylor, Jr.
Also filed as: TAYLOR CHARLES P JR · TAYLOR CHARLES PRICE · TAYLOR JR CHARLES P · TAYLOR JR CHARLES PRICE
13 granted patents·16 pending applications·268 citations·filing 1993–2009
93Inventor score
Top patents by PatentIndex Score
29 records- 0194US7381747B2Alpha 2 delta ligands for post-traumatic stress disorderWARNER LAMBERT CO·Filed 2006·Granted Jun 3, 2008·8 cites·2 claims
- 0292US6242488B1Method for preventing and treating painUNIV OKLAHOMA·Filed 2000·Granted Jun 5, 2001·62 cites·12 claims
- 0386US6127418AGABA analogs to prevent and treat gastrointestinal damageWARNER LAMBERT CO·Filed 1998·Granted Oct 3, 2000·81 cites·27 claims
- 0484US6426368B2Method for preventing and treating alcoholismWARNER LAMBERT CO·Filed 2001·Granted Jul 30, 2002·20 cites·10 claims
- 0577US7164034B2Alpha2delta ligands for fibromyalgia and other disordersPFIZER·Filed 2003·Granted Jan 16, 2007·7 cites·5 claims
- 0674US6329429B1Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseasesWARNER LAMBERT CO·Filed 1998·Granted Dec 11, 2001·42 cites·10 claims
- 0772US7432299B2Method of treatment for sexual dysfunctionPFIZER·Filed 2003·Granted Oct 7, 2008·4 cites·12 claims
- 0869US6887902B2Anti-inflammatory method using gamma-aminobutyric acid (GABA) analogsUNIV TEXAS·Filed 2001·Granted May 3, 2005·4 cites·14 claims
- 0969US2011039899A1Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPHPFIZER·Filed 2008·Application pending·0 cites
- 1061US5942513APharmaceutical composition and a method for treating neurodegenerative diseases using a combination of a kainate excitatory amino acid antagonist and an uricosuric agentWARNER LAMBERT CO·Filed 1998·Granted Aug 24, 1999·12 cites·10 claims
- 1161US5407935APharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonistWARNER LAMBERT CO·Filed 1993·Granted Apr 18, 1995·10 cites·4 claims
- 1261US2007293570A1Pharmaceutical uses for alpha2delta ligandsWARNER LAMBERT CO·Filed 2007·Application pending·0 cites
- 1361US2007161707A1Pharmaceutical uses for alpha2delta ligandsWARNER LAMBERT CO·Filed 2007·Application pending·0 cites
- 1461US2007276039A1Pharmaceutical uses for alpha2delta ligandsWARNER LAMBERT CO·Filed 2007·Application pending·0 cites
- 1561US2007213401A1Pharmaceutical uses for alpha2delta ligandsWARNER LAMBERT CO·Filed 2007·Application pending·0 cites
- 1661US2007161706A1Pharmaceutical uses for alpha2delta ligandsWARNER LAMBERT CO·Filed 2007·Application pending·0 cites
- 1760US2004180958A1Method of treatmentFiled 2003·Application pending·0 cites
- 1860US2008207755A1Alpha 2 Delta Ligands For Fibromyalgia and Other DisordersPFIZER·Filed 2008·Application pending·0 cites
- 1956US2004143014A1Therapeutic use of alpha-2-delta ligandsPFIZER·Filed 2003·Application pending·0 cites
- 2055US2004132636A1Pharmaceutical uses for alpha2delta ligandsFiled 2003·Application pending·0 cites
- 2151US2007238749A1Alpha2delta ligands for the treatment of fibromyalgia and other disordersTAYLOR CHARLES P JR·Filed 2007·Application pending·0 cites
- 2251US2009203782A1Alpha 2 Delta Ligands for Fibromyalgia and Other DisordersPFIZER·Filed 2009·Application pending·0 cites
- 2348US2004138305A1Alpha2delta ligands for the treatment of fibromyalgia and other disordersFiled 2003·Application pending·0 cites
- 2446US5627168APharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonistWARNER LAMBERT CO·Filed 1995·Granted May 6, 1997·4 cites·4 claims
- 2544US2004180959A1Gabapentin analogues for fibromy algia and concomitant disordersFiled 2003·Application pending·0 cites
- 2641US6133299AMethods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compoundsWARNER LAMBERT CO·Filed 1993·Granted Oct 17, 2000·12 cites·18 claims
- 2739US5767119AMethod of treating neurodegenerative diseases using an AMPA excitatory amino and an uricosuric agentWARNER LAMBERT CO·Filed 1996·Granted Jun 16, 1998·2 cites·14 claims
- 2838US2002058706A1Method for treating asthma using pregabalinFiled 2001·Application pending·0 cites
- 2938US2005059654A1Method for treatment of depression and anxiety disorders by combination therapyFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles Price Taylor, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →